XML 28 R10.htm IDEA: XBRL DOCUMENT v3.24.1
SEGMENTS
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SEGMENTS

4. SEGMENTS

 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision–making group, in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision-maker is the CEO. The Company operates in and reports four business segments: real estate, digital transformation technology, biohealth, and other business activities. The Company’s reportable segments are determined based on the services they perform and the products they sell, not on the geographic area in which they operate. The Company’s chief operating decision maker evaluates segment performance based on segment revenue. Costs excluded from segment income (loss) before taxes and reported as “Other” consist of corporate general and administrative activities which are not allocable to the four reportable segments.

 

The following table summarizes the Company’s segment information for the following balance sheet dates presented, and for the years ended December 31, 2023 and 2022:

 

   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Year Ended on December 31, 2023                         
Revenue  $20,963,661   $28,117   $12,758   $1,083,971   $22,088,507 
Cost of Sales   (13,915,144)   (9,145)   (54,529)   (597,391)   (14,576,209)
Gross Margin   7,048,517    18,972    (41,771)   486,580    7,512,298 
Operating Expenses   (1,312,024)   (468,679)   (869,683)   (7,734,566)   (10,384,952)
Operating Income (Loss)   5,736,493    (449,707)   (911,454)   (7,247,986)   (2,872,654)
Other Income (Expense)   47,363    (6,066,133)   (593,994)   (51,700,965)   (58,313,729)
Net Income (Loss) Before Income Tax   5,783,856    (6,515,840)   (1,505,448)   (58,948,951)   (61,186,383)

 

   Real Estate   Digital Transformation Technology   Biohealth Business   Other   Total 
                     
Year Ended on December 31, 2022                         
Revenue  $3,088,628   $69,915   $753,651   $568,248   $4,480,442 
Cost of Sales   (3,016,200)   (23,423)   (523,534)   (168,833)   (3,731,990)
Gross Margin   72,428    46,492    230,117    399,415    748,452 
Operating Expenses   (1,479,674)   (414,167)   (850,044)   (5,093,941)   (7,837,826)
Operating Income (Loss)   (1,407,246)   (367,675)   (619,927)   (4,694,526)   (7,089,374)
Other Income (Expense)   5,885    (1,359,977)   (4,669,309)   (33,099,730)   (39,123,131)
Net Income (Loss) Before Income Tax   (1,401,361)   (1,727,652)   (5,289,236)   (37,794,256)   (46,212,505)
                          
December 31, 2023                         
Cash and Restricted Cash  $3,323,210   $430,807   $568,702   $23,566,574   $27,889,293 
Total Assets   62,989,233    5,845,269    2,450,876    55,028,650    126,314,028 
                          
December 31, 2022  $2,592,577   $514,260   $1,338,404   $14,076,662   $18,521,903 
Cash and Restricted Cash   57,951,324    3,184,416    4,861,615    87,492,981    153,490,336 
Total Assets